Sochaczew

Poland

35 total trials 10 recruiting

Filter these 35 trials by phase, condition, sponsor and more.

Open in Search →

Randomized, Double-Blind, Placebo and Active Comparator Controlled Phase 3 Study for Moderate to Severe Plaque Psoriasis to Evaluate Efficac … Ended

2023-508959-39-00 5 2025-02-20 Moderate to Severe Plaque Psoriasis
A dose-finding trial with LU AG90222 in adults with migraine who have not been helped by prior preventative treatments. Ended

2023-508821-28-00 4 2024-08-14 Migraine
A study on the immune response, safety and the occurrence of RSV-associated respiratory tract illness after administration of RSV OA vaccine … Ended

2023-509455-13-00 11 2024-08-05 Respiratory Syncytial Virus Infections
A Phase 3 Study to Evaluate the Efficacy, Safety, and Tolerability of TAK-279 With a Randomized Withdrawal and Retreatment Period in Subject … Ended

2023-505842-24-00 5 2024-05-07 Moderate to Severe Plaque Psoriasis
Dose-response characterization of VER-01 in the treatment of patients with chronic non-specific low back pain Ended

2023-507358-34-00 4 2024-02-13 For the treatment of patients with chronic non-specific low back pain
A Phase 2 study (NEPTUNE-17) to evaluate efficacy and safety of GSK3858279 in DPNP. Ended

2022-502313-28-00 4 2023-12-14 Diabetic Peripheral Neuropathic Pain
Open-label trial to check the safety and tolerability of RTX-GRT7039 injections for pain associated with osteoarthritis of the knee. Ended

2024-515709-24-00 5 2022-07-26 Moderate to severe pain associated with Osteoarthritis of the knee
Assessment of the Efficacy, Safety, and Tolerability of AVP-786 for the Treatment of Agitation in Patients With Dementia of the Alzheimer's … Ended

2023-504990-19-00 5 2021-04-06 Agitation in Patients With Dementia of the Alzheimer's Type
A Randomized, Double-blind, Parallel-group, Active-controlled Study to Compare the Efficacy, Pharmacokinetics, Pharmacodynamics, Safety, and … Ended

2024-512417-41-00 5 Osteoporosis
A Phase 2, Multicenter, Randomized, Double-blind, Placebo-controlled, Dose-ranging Study to Evaluate the Efficacy and Safety of Abiprubart i … Ended

2024-512986-15-00 4 Sjögren’s Disease
CHRONDI Ended

2024-513595-17-00 4 CHRONIC PAIN DUE TO DIABETIC PERIPHERAL NEUROPATHY

Showing 25–35 of 35 trials